| Date Filed | Type | Description |
| 03/24/2014 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/20/2014 |
SC 13D/A
| GAMCO INVESTORS, INC. ET AL reports a 0% stake in Cadence Pharmaceuticals, Inc. |
| 03/19/2014 |
SC 13D/A
| GAMCO INVESTORS, INC. ET AL reports a 3.2% stake in Cadence Pharmaceuticals, Inc. |
| 03/19/2014 |
8-K
| Quarterly results |
| 03/19/2014 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 03/19/2014 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 03/13/2014 |
SC 13D
| GAMCO INVESTORS, INC. ET AL reports a 2.5% stake in Cadence Pharmaceuticals, Inc. |
| 03/10/2014 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 03/10/2014 |
SC 13G/A
| Capital Research Global Investors reports a 1.5% stake in Cadence Pharmaceuticals, Inc. |
| 03/07/2014 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 03/07/2014 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 03/06/2014 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 02/28/2014 |
10-K
| Annual Report for the period ended December 31, 2013 |
| 02/28/2014 |
8-K
| Quarterly results |
| 02/27/2014 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/25/2014 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
| 02/20/2014 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 02/19/2014 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party: |
| 02/18/2014 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 02/14/2014 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 02/14/2014 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a 6% stake in Cadence Pharmaceuticals, Inc. |
| 02/13/2014 |
SC 13G/A
| Versant Affiliates Fund II-A, LP reports a 6.4% stake in Cadence Pharmaceuticals, Inc. |
| 02/13/2014 |
SC 13G/A
| PRICE T ROWE ASSOCIATES INC reports a 7.2% stake in CADENCE PHARMACEUTICALS INC |
| 02/12/2014 |
SC 13G/A
| Capital Research Global Investors reports a 7.1% stake in Cadence Pharmaceuticals, Inc. |
| 02/11/2014 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 02/11/2014 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 02/11/2014 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 02/11/2014 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 02/11/2014 |
8-K
| Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other E...|
Docs:
|
"Agreement and Plan of Merger, by and among Mallinckrodt plc, Madison Merger Sub, Inc. and Cadence Pharmaceuticals, Inc",
"Second Amendment to Amended and Restated Bylaws of Cadence Pharmaceuticals, Inc",
"Tender and Support Agreement, by and among Mallinckrodt plc, Madison Merger Sub, Inc. and certain stockholders of Cadence Pharmaceuticals, Inc",
"MALLINCKRODT PLC TO ACQUIRE CADENCE PHARMACEUTICALS, INC. FOR $14.00 PER SHARE, IN CASH" |
|
| 02/05/2014 |
SC 13G/A
| BAY CITY CAPITAL LLC reports a 3.4% stake in Cadence Pharmaceuticals, Inc. |
| 01/30/2014 |
8-K
| Entry into a Material Definitive Agreement |
| 01/28/2014 |
SC 13G
| BlackRock Inc. reports a 6.2% stake in CADENCE PHARMACEUTICALS INC. |
| 01/13/2014 |
8-K
| Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits |
| 01/10/2014 |
SC 13G/A
| FMR LLC reports a 3.4% stake in CADENCE PHARMACEUTICALS INC |
|